Botulinum toxin type A was first used for the treatment of spasticity in 1989. A small uncontrolled study of treatment of upper limb spasticity after stroke reported encouraging benefits, including ...
Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that it has completed the ...
Botulinum toxin therapy has emerged as a pivotal treatment in the management of spasticity, a debilitating neuromuscular condition characterised by increased muscle tone and hyperactive reflexes. By ...
Dry needling has emerged as a minimally invasive intervention utilised in neurorehabilitation to manage spasticity, particularly following stroke. This technique involves the insertion of fine needles ...
DelveInsight’s "Muscle Spasticity Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Muscle Spasticity pipeline landscape. It covers the ...
Thanks to new high-frequency electrical stimulation that blocks spasticity, two paralyzed patients suffering from muscle stiffness after spinal cord injury benefit from rehabilitation protocols for ...
Spasticity is a condition that causes your muscles to stiffen, tighten, and contract. It happens involuntarily, which means you don’t have control over it. Spasticity typically happens because of ...
The most common type of CP diagnosed in the premature population is spastic CP. These infants are usually initially hypotonic, with spasticity developing over time. Spasticity is characterized by ...
If you or a loved one have suffered a stroke, a brain or spinal cord injury, or are living with cerebral palsy or multiple sclerosis (MS), you might be familiar with a condition called spasticity, ...
Cerebral palsy can cause muscle spasms and many other hypertonic symptoms. The symptoms can be treated in a variety of ways, often starting with physical therapy. Cerebral palsy (CP) is a group of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results